PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Antibody, IgG2b, Clone: [PDL1/2746], Mouse, Monoclonal

Catalog Number: NBT-29126-MSM6-PE-100T
Article Name: PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Antibody, IgG2b, Clone: [PDL1/2746], Mouse, Monoclonal
Biozol Catalog Number: NBT-29126-MSM6-PE-100T
Supplier Catalog Number: 29126-MSM6-PE-100T
Alternative Catalog Number: NBT-29126-MSM6-PE-100T-0.5,NBT-29126-MSM6-PE-100T-500
Manufacturer: NeoBiotechnologies
Host: Mouse
Category: Antikörper
Application: ELISA, FC, IF, IHC, WB
Species Reactivity: Human, Mouse
Immunogen: Recombinant fragment (around aa 39-191) of human CD274 (PD-L1) protein (exact sequence is proprietary)
Alternative Names: B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1
PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.
Clonality: Monoclonal
Clone Designation: [PDL1/2746]
Molecular Weight: 37-50kDa
Isotype: IgG2b
NCBI: 29126
UniProt: Q9NZQ7
Form: 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Antibody Type: Monoclonal Antibody
Application Notes: Flow Cytometry (1-2ug/million cells), Immunofluorescence (1-2ug/ml),,Optimal dilution for a specific application should be determined.